We are excited to have Chief Business Officer Rachel Lane and Vice President of Proteomics Sherry Niessen featured in an article on protein-protein interactions in Genetic Engineering & Biotechnology News. Rachel and Sherry spoke about the importance of finding novel approaches to access undruggable protein targets by using chemical probes.
Our CEO Jeff Jonker sat down with Endpoint News to discuss Belharra’s new podcast series “Birth of a Biotech.” In the article he discusses the reason behind starting the seven-episode podcast series and his hopes for creating something that will start a conversation on research, clinical developments, and patient treatments.
Read more:
hhttps://endpts.com/belharra-ceo-talks-the-ins-and-outs-of-building-a-biotech-in-a-new-podcast/
We are honored to have Fierce Pharma feature Belharra in an article about our Birth of a Biotech podcast and the history behind how we got where we are today. The article also features Belharra’s CEO, Jeff Jonker, who talks about what makes the podcast resonate so well with listeners.
Belharra is so proud to have one of our own, Mike Lazear, be named as one of the Rising Stars in Proteomics and Metabolomics by JPR. This list recognizes emerging scientists in the fields of proteomics and metabolomics selected by the Associate Editors of the Journal of Proteome Research (JPR) and the Editorial Advisory Board members.
Read more:
https://pubs.acs.org/doi/10.1021/acs.jproteome.3c00868
BioSpace came up with a list of life science startup companies to watch in 2024 that launched with Series A funding between September 2022 and September 2023 and Belharra is so proud to be a part of this exciting list!
We were so honored to have our CEO Jeff Jonker be a guest on The Long Run with Luke Timmerman, a biotech podcast that focuses on innovations and emerging trends for anyone seeking to understand new drug development diagnostics, genomics, and other technologies that are changing medicine. Jeff spoke with Luke in a podcast titled “The Small Molecule Drug Discovery Renaissance.”
Listen here:
https://timmermanreport.com/2023/12/the-small-molecule-drug-discovery-renaissance-jeff-jonker-on-the-long-run/
C&EN came up with a list of 10 chemistry start-ups to watch in 2024 based on reader submissions and reporters who talked to chemists and entrepreneurs. We’re so proud to be among this impressive list!
Read more about our story:
https://cen.acs.org/business/start-ups/CENs-2023-10-Start-Ups-Watch/101/i37?sc=230901_cenrssfeed_eng_latestnewsrss_cen#